call. Vivan and Thank morning, earnings to Welcome XXXX good you, third everyone. quarter Nuwellis
who welcoming Officer, to new financial give this behalf will to of like on Lynn would be by George performance will First, asset that closing before position opening followed our quarter also missed. remarks then the Nuwellis to and Lynn an On value third overview confident the would Financial George an our And detailed I'd like on I of all by Montague up Lynn for Chief the thank for will call, results for to this significant our on company. call stakeholders team Nuwellis the XXth. team, and be create the start Blake, I started of October to in Nuwellis. provide his like an questions. initiatives. contributions provide strategic today's update call significant I'm my
significant double-digit on momentum the gained During revenue and we key third achieved quarter, growth initiatives. our year-over-year strategic
will and system of focused In balance continue progress value, product, on initiative, a as remains for restoring product strategic the provide our of clear continuous device. heart education Aquadex of rollout these replacement systems, team our of build on to the on clinical which steady focused fluid Aquadex making of an executing our out the and treating following standard economic clinical supporting with update our strategy. clinical renal goal Penetration our data sales Our our pediatric I care remarks, ambulatory include initiatives. failure pipeline therapy clinical of development new continued each our patients, and such my
that Before you doing not and mission, so, everything team work do, dedication at your without be of I would hard our and like exciting to we entire to new thank possible growth. point we the make will this well
growth strategy to for quarter X% turning In quarterly traction. decline representing this now the saw Turning, second pleased XXXX, diversify are significant see compared to year implemented we our third we quarter to XXXX to over third of expansion of therapy million, failure quarter Compared Revenue XX% the to was as results. growth of our base gain XX%. strategy and our late the to $X.X of a continues heart year XXXX. and XXXX, of beyond
was in driven our segment. helping our third we results pediatric reflect increase to forward a and we increase decided part and this year-over-year to patient revenue business on our Since by trends more customer children overload population, seen focus relatively second basis, sequential efforts the off our strong look follows seasonal we large typical The quarter pay quarter. fluid have in On come. a suffering in from years to
is quarter further was from off our Increasing heart in and pediatric, demonstrates critical from failure. again revenue support. paying from mix XX contribution third investment XX% our pediatric that and Our from provides care, patient this business XX% population
pediatric we to XXXX, our implemented strategy customer the grew expansion late beginning compared XXX%. in third XXXX quarter segment of the For
by same. X% care the critical and declined our segment heart failure customer remained Our segment
to new three in smart our has this our install third In versus well This ultrafiltration period of accounts incorporated are the sold expenses specialty We the spent continued XX in positioning eight for increased quarter, well guide Throughout ultrafiltration multiple units the accounts. use accounts the decrease We into possible aquatic within allowed in put for This of us the reception expenses our positioning, in have in and quarter by research which as year hospital, generation consoles on quarter, in the aqua third our and including efforts of to in pediatric we customers consoles new period. of on the five is initiatives, development of tell our focusing period total as operating positive total that and utilization allocation our therapy, a latest flow prior the the by and effectively sold manage encouraged of base field investments reactivated have console, decreased us that clinical while our our therapy. adoption smart increasing hiring steady and new XX the personnel, XX%. our to three incorporates added strategic a the capital we progress us diagnostics system device.
initiatives on key provide strategic a our four outlined update earlier. Next, I would to like business
initiative our strategy. and first of is implementation focused the Our sales new
drive utilization As gains over to we improvements. in strategic this note and accounts in nature. our growth locations high volume show significant and accounts have we The target continue previously mentioned, this ability create is of of our is where are in XX both top to goal rate strategy geographic year a confident year in utilization operational to
increasing our ultrafiltration patient's inpatient care our continue of of they not trained doing, whom on of successful our our hiring includes CES system. supporting within our facilitate specialists also patient with team make role of on In use therapy. partner The and our all optimal only the an which expansion, but so directly CES, key field progress the the organization nurses also plays outpatient use outcome We manager important to education facilities, the or account clinical CES.
term, track We Longer are on sales with supporting clinical number that March activities. of manager. this of we account plan are were, to remain education specialist continue encouraged in hires year clinical targeted to specialists maintain clinical We hiring by we that that education have and year. invest end and a throughout we successful ratio the were the to to team of our one staffing our shortages of widespread ease our last beginning been complete two
utilization two internal equates show the stronger, increase one to and growth. Our efficiency greater more that metrics sustainable accounts, within ratio this to
active strategic initiative CCPT and the dedicated of to January the we of three outpatient aquatics but American to second Medical who outpatient to year, been reimbursement. heart from CMS our therapeutic ultrafiltration been reactivate clinics our had in therapy conversations assignment patients category due for The discontinued target this code new In lack using failure Association. following have of clinics treating is from
our noted, administered reimbursement in setting. previously three CPT for ultrafiltration category code As outpatient provides
increasing in this the admissions they there world on likely broader Our inpatient outpatients to constructive been outpatient hospitalizations next to reimbursed opportunity in can CCPT reactivate clinics and facilities data have well conversations to years. the real of reimbursement to two support obtain readmissions to category that reduce to potential code and fluid happen welcome and due as received an of three to is these because patients, one and overload leverage patient generate
performed historically also made and centers market. in penetrate the building similar to laying awareness have progress develop foundation this We therapies that outpatient have
grow enrolment to the Our wellness third a reverse is evidence. announce On first heart in the of new the pivotal clinical key patient body June representing HF strategic trial milestone of XXth, initiative company. we aqua reminder, diuretics. between HF for loop and as therapy At the primary days evaluate events failure intravenous effectiveness and within XX reverse heart will endpoint a mortality comparison of XX and
to the University to Morton the additional September in Hospital activation update we Abington Baker this Plant Pennsylvania, were three Francisco, pleased of of in San an sites, XX, announce trial Florida. Jefferson As on Hospital and California,
in clinical to least we study. XX addition these additional sites, In participate anticipate at institutions to this
for many benefits their doctors patients. the making in are the to grateful ultrafiltration and contribution are gathering additional in who of supporting possible this therapy study heart failure evidence We
fluid committed ultrafiltration believe goal of the trial healthcare of in care a society in management to therapy which company, are would therapy many diuretics. have care. additional the overloaded as will patients medical guidelines, will the for to of provide As more We benefits it we benefiting are unresponsive fluid patients that future a standard to be ultimate aquatics economic to the lead evidence evidence making of successful standard from within needed including the practice aquatics included
the review XXst, per are provide front, year Additionally, cabbage new approximately seven context data of large first performed cabbage XXX,XXX highlights there worldwide, patients representing to are at physician the clinical in which of very XX for for high estimated managing balance provides a customers. artery To for the this risk fluid on high ultrafiltration Of this, safe patient marketing XXX,XXX in an of bypass reducing grafting peer Aquadex hundred risk mortality ultrafiltration wells. these on data therapy rates. exciting risk or method This around high on indication, the XX% This cabbage study new and performed opportunity a was procedures prevalence of kind us. this of are benefits its for patients patients. results population. for of postoperative clinical are coronary for survival and our following we publication percent This demonstrating new days announced August use the shows effective and and the the
the presented America's on front, XXXX superior a Heart aqua Lastly, of statistical reducing the Society Failure heart failure of study demonstrating AVOID-HF at Annual results clinical new clinical mortality clinical in of the events benefit the September. the in therapy Meeting Scientific were and
new fluid patients. The review overload superior for As using and this for manuscript we significant the the results in study in provide heart expected, potential for is creating savings failure analysis a improving the submitted being quality ultrafiltration the peer a to of benefit to from of diuretics cost ultimately hospitals journal. for statistically over publication demonstrated patients, life
will data that at standard continue longstanding One to in treating this Aquadex made the make clinical we We of have and that in the to data this ultimately fluid is effectiveness and field strong develop third quarter. suffering of forefront patients a on the clinical our from therapy strategy of will developed have goals strides the it Nuwellis' major care. believe overload. the to demonstrate put We
the strategic development on Finally, initiative product front. our fourth is
We continuous continue the on progress to make our quarter therapy pediatric replacement device. in renal
rolling experienced significant remain and serve order are many an we children traction help as this that best pediatric as IDE We customer to device patient our to anticipating XXXX. and out in have submission to by possible population, segment in committed early
property. technologies, our intellectual are highly investing committed in protecting pipeline our including We to
for and sustainable that innovation development, balance. new investments make growth quarter, patent strategy intellectual property the the conclusion, we targeting restoring our remains We fluid US balance and doing with the During same is that care safety hemofiltration. our and and generation, setting new and outpatient for In a Aquadex in product sales strengthen come. portfolio the standard pediatric now new dialysis therapy, improved the facilities believe stage novel we goal for a of a of the data to terms are work fluid years in focused clinical implementing in for strong to
discuss the new our like Officer, Lynn Blake, Now, to financial results. over to the QX call I Chief would turn to Financial
